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ABSTRACT

DETECTING VIRAL PARTICLES IN VITRO USING PHOTOACOUSTIC FLOW
CYTOMETRY

By
Anie-Pier Samson
December 2021
Thesis supervised by Dr. John Viator
The Covid-19 pandemic is a powerful example of just how damaging the rapid spread of an
unknown virus can be. Viruses have the ability to spread rapidly amongst individuals if not
treated and controlled. The first key step towards treatment is the timely and specific diagnosis of
the virus causing the infection. An innovative method for the rapid detection of viral particles in
solution consists of tagging the viral particles paired with using photoacoustic flow cytometry to
irradiate the particles and get a signal. The high affinity of Streptavidin for Biotin can be used to
bind Streptavidin-coated microspheres to biotinylated antibodies. Monoclonal antibodies will be
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used to make sure that each one of them can only attach to one antigen on each viral particle.
Using microspheres allows for a close approximation of the number of microspheres that can
bind to each viral particle at a rate of approximately 6 microspheres per virion. However, the
margin of error is thought to be high, due to the small difference between the detection signal
threshold between one single particle and six of them bound together. The solution to eliminate
this error resides in a multi-step process resulting in engineered microsphere complexes that can
be detected by the system. Increasing the microsphere complex size by at least 3 orders of
magnitude allows us to maintain the detection signal threshold to detect the particles at the
standard threshold. Using photoacoustic flow cytometry to detect viral particles was never
attempted before and would expand the range of applications for this system.
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CHAPTER 1: INTRODUCTION
Globalization only means viral infection when devastating consequences are involved.
Viral infections are among the top cause of mortality worldwide, and with accessibility to new
environments being so open, viruses have a greater chance to spread among and infect
populations [1]. With this global burden becoming an increasing threat, as it was experienced
with the coronavirus 2019 outbreak, there is a need for methods that can provide rapid and costeffective diagnostics. By detecting and accurately identifying the virus responsible for an
infection, controlling the spread of the infection becomes easier and requires less resources.
Viral particle detection is generally done by identifying viral particles, RNA or DNA,
antigens, or specific antibodies [2]. Currently, viral particles assays are done using mainly solidphase immunoassays, cell culture, polymerase chain reaction (PCR), antibody agglutination, and
antigen testing. The current benchmark for viral particle identification is PCR which allows for
semi quantitative precises quantification of the number of viral particles in a clinical sample. It
also has the ability to identify viral oligonucleotides, a piece of information crucial to reflect
viral replication and the active infection rate. However, this method is very timely as it takes
days to develop a sample to the point where it is ready to be processed. PCR also often happens
to be affected by multiple factors like the salinity of the environment, the concentration of
particles, and other inhibitors. The high-cost and need for trained personnel would also be cons
of using PCR if a better method came along. Another method of viral detection is solid-phase
immunoassays (SPIs). This method can detect viral antigens in a sample rapidly and reliably. It
works by immobilizing antibodies to a reliable support. Viral antigens will then bind to the
specifically selected antibodies and effectively assess the number of viral particles of that type
1

present in solution. The high specificity of this technique renders it very attractive for
researchers. However, this process is so simplified that it is not as reliable as PCR and is timely.
The problems with antibody agglutination and antigen testing are that they both require a large
concentration of viral particles to be accurate and they both are not quantitative. All combined,
these methods still cannot detect close to a third of the respiratory viral infections, viral
gastroenteritis, and viral encephalitis [3]. Therefore, it is clear that the viral particle detection
area can use a more rapid, efficient, specific, and cost-effective way to analyze a viral sample. A
fully comprehensive diagnosis that can be combined with point-of-care applications would have
a significant impact on controlling the spread of viral infections at the source. Infected
individuals can be rapidly isolated and treated appropriately, minimizing the collateral medical
and emotional costs. The need for a better way to readily quantify the number of viral particles in
a complex sample can be met by the introduction photoacoustic flow cytometry in the vast world
of in vitro viral assays.
1.1 PHOTOACOUSTIC FLOW CYTOMETRY

Photoacoustic flow cytometry (PAFC) uses the photoacoustic effect to detect the desired
analytes in a sample. The photoacoustic effect can be described as the induction of sound waves
produced from an optical source also referred to as laser-induced ultrasound. The two base
components of any photoacoustic system are the pulsed laser and transducer. Lasers are able to
deliver precise wavelengths and energy to a sample in defined amounts of time. Transducers are
commonly used in many industrial applications from depth profiling to prenatal ultrasound
machines. The photoacoustic flow cytometry set up is illustrated in figure 1. In Photoacoustics,
the absorption of laser energy causes a rapid heating and cooling of an object resulting in
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thermoplastic expansion and contraction. This expansion and contraction phenomenon is
characterized by a condition known as stress confinement. Stress confinement of an object is
determined by the physical properties of each cell and the time frame that laser energy is
deposited. When an object is under stress confinement it will expand and contract creating
pressure waves that can be detected [4]. Photoacoustic flow cytometry takes advantage of these
characteristics for detection of objects under flow. The flow chamber in which this process takes
place can be seen in figure 2.
PAFC has been a great contender in the diagnostics world for many years. Shashkov et
al. demonstrated the ability to detect particles under flow in vivo by labeling the particles of
interest with carbon nanotubes or gold nanorods [5]. The extensive work of Edgar et al. with
PAFC detected circulating tumor cells in a blood sample by using the intrinsic melanin in the
cells as photo absorber. Edgar et al. also demonstrated the ability to detect bacteria in vitro by
tagging bacterial cells with bacteriophage. This technology has the ability to detect rare particles
in solutions by making use of the photoacoustic effect [6] The key element into detecting any
particles with this system is the photo absorbing element. If the particle of interest does not
inherently contain a sufficient amount of photo absorbing matter, it needs to be tagged with a
light absorbing element. PAFC has already been used to detect melanoma and bacterial cells in
complex environments [6, 7]. The next logical step is to use the versatility of the system to detect
viral particles in a more timely and accurate fashion than the current detection methods can.
Virions, unlike circulating tumor cells (CTC’s) or bacterial cells, lack some essential components
to be easily detected. Accordingly, special tagging complexes were engineered to allow the
PAFC system to detected undetectable viral particles.

3

1.2 ANALYTE DISTINCTION
The difference in size between all three categories of particles also greatly affects
detection. The average diameter of a melanoma cell is 18µm and the average diameter of a
bacterial cell ranges from 0.5 to 5µm. However, the average diameter of a viral particle ranges
from 20-500 nm. The multiple orders of magnitude difference between the three categories mean
that an alternate method of detection must be used to detect viral particles. The detection of
melanoma cells can be achieved because of the intrinsic melanin found in the cells which acts as
a photo absorber. Bacterial cells, having intrinsically no photo absorbing component, can be
detected by using tagged bacteriophage as photo absorbers. Viral particles lack an intrinsic
photo-absorbing component. Tagging the viral particles with naturally-occurring tags of
adequate size presents a difficulty due to their small size. Using this tagging technique,
specifically designed and manufactured photo-absorbing tags have been developed for virion
detection using the PAFC system.

4

Figure 1: Schematics of the photoacoustic flow cytometry system

Figure 2: Schematics of labeled photoacoustic flow chamber

1.3 DETECTION OF VIRAL PARTICLES
Simian Virus 40 is one of the best known and studied viruses in the world. It was
originally discovered as a contaminate of the Salk Polio vaccine and quickly became a model
virus of Virology and host interactions [8]. Polyomaviruses such as Simian Virus 40 (SV40) are
known to be of the simplest viruses with double-stranded DNA genomes. Because of its
simplicity and widely understood mechanisms, the SV40 system has been used to study a wide
range of processes within the immunology and molecular biology worlds [9]. SV40 was chosen
as the viral model for this assay because of its simple icosahedral structure and the vast amount
of knowledge collected over the years on its mechanisms. Icosahedral symmetry plays an
important role in the study of viral capsid proteins, eventually leading to more knowledge on the
viral structure made out of asymmetric blocks [10].
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SV40 virion particle self-assemble from a single repeating subunit called VP1. The
capsid is built from 72 pentamers, each contains five VP1 subunits, for a total of 360 VP1
identical subunits in the mature capsid [11]. For this reason, any tag or antibody that attaches to
the VP1 subunit of SV40 will have multiple binding positions equally distributed on the exterior
of the virion particle. Antibodies to VP1 have been attached to photo-absorbing microspheres
and these antibody-covered microspheres can attach to the capsid of SV40. This yields a bundle
of microspheres that are bound to individual viral particles. SV40 has a diameter of 45nm while
a microsphere has a diameter of 0.19µm. The size difference between one microsphere and one
viral particle allows for one microsphere to bind to each side of the viral particle. Thus, one
virion becomes surrounded by six microspheres, creating the first microsphere complex (MC1).

Figure 3: Representation of MC1
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The diameter of the detectable unit then increases from 45nm to 0.425 microns. However,
even though the microsphere complex gives a tenfold increase from the initial undetectable size
of a single virion, it gives rise to a new problem. The difference in diameter between a single
free-floating microsphere and that of a microsphere complex is only 0.235micron. The size of the
difference between the two analytes is not big enough for the PAFC system to be able to
distinguish them from each other. As comparison, in the bacterial detection model, the difference
in size between a single tagged phage (~0.1µm) and a tagged bacterial cell (~1µm) is at least a
tenfold increase. Bacterial detection is achieved by using units that are much smaller than the
desired analytes. This technique uses the same concept, but binds significantly bigger units to the
desired analytes. Although these two techniques seem very similar, one problem arises from the
difference in size between virions and microspheres. How to determine between a detection
obtained from a single free-floating microsphere and one obtained from a microsphere complex?
To alleviate this problem, the microspheres that are added first and bound to the viral
particles are covered in VP1, an antibody to SV40. Another antibody, which binds to a different
receptor protein than that of SV40 is also tethered to the microspheres constituting this first
layer. The second antibody/antigen pair consists of an adenovirus, Adenovirus Type 5 hexon
protein and an anti-adenovirus type 5 antibody. The second antigen is biotinylated to a second
sample of microspheres. After attaching the first layer of microspheres to the viral particles, a
second layer of microspheres is added. This time, those microspheres are coated in a different
receptor protein and will bind to the other antibodies present on the first layer of microspheres.
Adenovirus vectors have also been extensively studied and are well-understood.
Choosing another type of virus that uses a different attachment protein than that of SV40 is
crucial for the success of this study. Using two completely different antigen/antibody reactions
7

ensures the specificity of binding as well as eliminating the need of removing unbound
microspheres. For this study, the ADV type 3 antigen was chosen to be targeted by an antiadenovirus antibody. ADV type 3 is a naturally occurring antigen that is very stable and
commercially available.
The icosahedral structure of SV40 and the tenfold difference between the size of a
microsphere and the size of a virion mean that only one microsphere will be able to bind to each
side of the viral particle. By dissecting the MC1, one can observe that the diameter contains two
microspheres and one virion. The microspheres have a nominal diameter of 0.19µm and the
virion has a diameter of 0.045µm. The total diameter of MC1 adds up the be 0.425µm, yielding a
radius of 0.2125µm. The total volume of the microsphere complexes can be modeled as that of a
sphere. Thus, the volume of MC1 is:
4
3

𝜋(0.2125)3 = 0.0402µm3

By adding another layer of microspheres to the MC1’s, the new diameter of the new
microsphere complexes (MC2) is now 0.850µm. The volume of MC2 is therefore given by:
4
3

𝜋(0.425)3= 0.322µm3

Due to the volume of the microsphere complex resembles that of a sphere, doubling the
radius means that the volume is exactly 8 times greater after doubling the size of the microsphere
complex, thus the main focus of increasing the radius of the complex. In this volume range, the
photoacoustic flow system has already been proven to be able to detect tagged bacterial cells of
this size. Using anterior research and results, detecting viral particles can be achieved using
microsphere complexes because of their comparable size to a tagged bacterial cell. The size
comparison of the two microsphere complexes is illustrated in figure 4.
8

Using this technique of building a microsphere complex consisting of two layers of 0.19 µm
microspheres we are able to reliable detect signal viral particles without detecting single free
floating unbound microspheres. This method allows us to isolate and quantify viral particles in a
sample. Isolation of single viral particles can be very beneficial in studying heterogeneity in
virion population[12]. Additionally, single read sequencing technologies have now made single
particle research more practical and attainable to answer scientific questions previously
unattainable [13].

0.425µm

0.850µm
Figure 4: Size representation of the diameter of the two microsphere complexes
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CHAPTER 2: MATERIALS AND METHODS
CV-1 cells were used as the host cells for SV-40 replication. The growth media necessary
for optimal growth of CV-1 cells (ATCC CCL-70) is made by combining fetal bovine serum
(FBS) (ATCC 30-2020), pen/strep solution (ATCC 30-2300) and Eagle Minimum Essential
Medium (ATCC 30-2003). FBS and the pen/strep solution are thawed in a water bath (37˚C)
until completely thawed through. To obtain a concentration of 10% FBS in the growth medium,
add 50ml of FBS to a new 500ml bottle of EMEM. In order to eliminate the possibility of
bacterial contamination, 5ml of pen-strep solution were added to the growth medium to obtain a
concentration of 1%. Media was mixed thoroughly by agitating the mixture until all the
components are well combined. Containers were labeled and stored between 2 and 8˚C.
Aseptic technique was used when handling all media and cell lines. The Biohood is
sanitized with 70% ethanol solution and sterilized under the UV light for five minutes with every
use. Gloves are worn at all times and sterilized each time during the handling of cells to prevent
cell contamination. Aseptic technique was carried throughout all procedures as well as
performed in a biohood. Once the work surface is ready, the blower is turned on to eliminate the
possibility of outside contamination and to keep a sterile field. Two 15ml falcon tubes and a
falcon tube rack are sprayed with 70% ethanol and placed in the biohood. The assembled growth
medium, a 10ml serological pipette, and an automatic pipette are also disinfected and placed in
the biohood. Each item was carefully wiped down inside the biohood. Next, the dry-ice frozen
vial of CV-1 cells was thawed in a water bath at 37˚C. Once the content of the vial was
completely thawed, the vessel was sprayed and wiped down in the biohood. The cells were
added to a 15ml falcon tube followed by 10ml of growth medium. The lid was placed on the tube
before the tube was centrifuged at 1600rpm for 10 minutes at 24˚C. While the cells were being
10

centrifuged, a T-25 cell-culture flask was sterilized, labelled, and added to the biohood. After
centrifugation was completed, the falcon tube containing the cells was taken out of the
centrifuge, sterilized once again, and wiped down in the biohood. The cells formed a pellet at the
bottom of the tube. This allowed for the medium to be slowly aspirated in the second falcon tube
to leave the pellet undisturbed. 3ml of growth medium was added to the pelleted cells. The cells
were resuspended using a vortex and then added to the culture flask. The flask was carefully
sprayed down with 70% ethanol and placed in the CO2 incubator at 36.5˚C.
The growth medium was changed every 72 hours. Between changes, the cells were
observed under a light microscope (Leica DMI4000B). After the sanitation of the Biohood with
70% ethanol solution and decontaminated under the UV light for five minutes, the blower was
turned on. The cell flask was carefully sprayed with 70% ethanol solution and wiped off in the
Biohood. The growth medium, two 15ml falcon tubes, a falcon tube rack, a 10 ml serological
pipette, and an automatic pipette were sterilized and placed in the biohood before getting wiped
down. The cells were added to a 15ml falcon tube. The lid was placed on the tube before the tube
was centrifuged at 1600rpm for 10 minutes at 24˚C. The centrifuged tube was sprayed with 70%
ethanol solution before entering the Biohood and getting wiped down. The old medium was
discarded in the second falcon tube. 3ml of new growth medium was added to the pelleted cells
using the automatic pipet. The cells were resuspended using the vortex and poured back into the
same flask. The flask was carefully sprayed down with 70% ethanol and placed in the CO2
incubator at 36.5˚C.
Once the cells reached confluence, subculturing was performed. Following aseptic
technique, the culture medium was removed from the culture flask. The cell layer was rinsed
with 0.25% (w/v) Trypsin-0.53mM EDTA to remove all serum that contains trypsin inhibitor.
11

The flask was put under the microscope and 3ml of Trypsin-EDTA solution was added to the
flask. It is very important to not move the flask after adding the Trypsin-EDTA solution to the
flask to avoid the agglutination of cells. The cells were constantly monitored and observed under
the microscope to know when the extracellular matrix has dissolved and the cells are released.
Once complete dispersion was achieved, 6ml of growth medium was added to the flask. The
content of the flask was poured into a 15ml Falcon tube and centrifuge at 1600RPM for 10
minutes. The media on top of the pelleted cells was aspirated and 6 ml of new growth medium
was added to the tube. The cells were resuspended using a vortex and split evenly between two
new culture flasks. The flasks were labelled and place into the CO2 incubator. This process was
repeated once more when both flasks were confluent.
Once the CV-1 cells in the four flasks reached 80-90% confluence, SV40, also known as
Macaca mulatta polyomavirus 1 (ATCC® VR-1901™), was added to one of the flasks. The
SV40 aliquot was thawed in a water bath. The cells were inoculated with 1ml of SV40 to reach
an optimal MOI of 0.01. The flask was placed in the humidified 5% CO2 incubator for 2 hours
where the conditions are optimal for adsorption at 37˚C. To terminate the adsorption process, the
flask was taken out and 3ml of virus growth medium was added to the flask. The virus growth
medium is made out of EMEM (ATCC 30-2003) and 2% FBS (ATCC 30-2020). In a 500ml
bottle of EMEM, 10ml of FBS were added. 5ml of Pen-Strep solution was also added to a
concentration of 1%. The flask was then placed back in the CO2 incubator for a total of 12 days.
The cells were monitored after 6 days to ensure proper inoculation of the cells. Before harvesting
the virus, the culture flask containing SV40 was placed under a light microscope and the viral
particles were counted to find their approximate concentration. Pictures of a confluent cell layer
and SV40 layer can be seen in figure 5 on the left.
12

The cytopathic effect (CPE) is the structural changes in the host cell that result from the
viral infection of cells. It is caused by either the lysis of the host cells or the death of host cells
due to the inability to reproduce [14]. The CPE can be visualized in figure 5. Once CPE is
processed through about 80% of the monolayer, the content of the flask was collected and
filtered through a 0.45µm surfactant-free cellulose acetate syringe filter obtained from Fisher
Scientific (Titan3 syringe filter 17mm 0.45µm, 03050369). Two aliquots of 1ml were placed in
sterile Eppendorf tubes and 2ml of growth medium was added to the sample to avoid an
accelerated titer decrease due to small volume. The aliquots were stored at -80˚C.

Figure 5: Light microscope pictures of CV-1 cells (LEFT) and SV40 (RIGHT).
These two pictures show the cytopathic effect. The cells on the right have been
lysed and SV40 has reproduced.
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2.1 DETERMINATION OF PROTEIN CONCENTRATION
Antibodies were obtained from Abcam (Anti-SV40 VP1 ab53977) and (Anti-Adenovirus
Type 5 antibodies ab6982). Upon reception, the solutions were each split into two aliquots. 2µl
were placed on a Take3 plate. The Take3 program of the plate reader (Biotek Synergy H1
(Winooski, Vermont)) was used in pair with the Gen5 software to determine protein
concentration of the antibodies and Type 5 hexon protein. Sterile ultrapure water was used as a
reference for the program. The Beer-Lambert law was used to determine the protein
concentrations of the analytes [15]. The Beer-Lambert law is written as such:
𝐴 = 𝜀𝑙𝐶
Where A is the absorbance, ε is the protein extinction coefficient (mg/ml)-1cm-1, I is the
pathlength (cm), and C is the protein concentration (M). The path length of the plate reader is
0.05cm. The calculation of the protein concentration of the antibodies and antigen from their
absorbance is required to get a general idea of how much biotin to add later on. Therefore, we
can estimate the protein extinction coefficient to be 1(mg/ml)-1cm-1 for all analytes. Rearranging
the Beer-Lambert equation to get the concentration, we get

𝐶=

𝐴
𝑙𝜀

The absorbencies and concentrations were computed and are displayed in Table 1.

Analyte
Ab VP1
Ab Type 5
Hexon Protein Type 5

Absorbance
0.047
0.048
0.044

Concentration (mg/ml)
0.94
0.96
0.88

Table 1: Absorbance and calculated protein concentration for each of the antibodies
and antigen used.
14

2.2 PREPARATION OF MICROSPHERES
Streptavidin coated dyed polystyrene microspheres with nominal diameter of 0.19 µm
(Bangs Laboratories, CP01001) were obtained. In order to remove stabilizers and antimicrobial
agents used by the manufacturer, the microspheres were washed four times in 0.1M PBS.
Vivaspin Spin-X concentrator columns (Spin-X UF-500 Concentrator 500uL, 100,000 MWCO,
431481) were used to wash the microspheres.
2.3 BIOTINYLATING SP1 AND TYPE 5 ANTIBODIES
Biotin (Thermo Scientific EZ-Link Sulfo-NHS-Biotin) was prepared separately following
the Thermo Fisher protocol for biotinylating proteins [16]. Biotin was taken out of the freezer
and allowed to reach room temperature before being used. Thermo Fisher provides a calculation
sheet based on experiments ran with different protein and reagent concentrations. According to
these experimental calculations, when a 20-fold excess of biotin was added to a 1-10 mg/ml
antibody solution, the results were that 4 to 6 biotin groups bound to each antibody molecule.
This concentration of biotin reagent on antibodies suits the desired amount to assemble to
microsphere complexes. Thus, because of the concentration of SP1 antibody is 0.94 mg/ml and
the concentration of the Type 5 antibodies is 0.96 mg/ml, a 20 fold excess meant that it was
necessary to add 20mg/ml of the biotin reagent to each solution. The PDF used for calculations is
added as a reference [17]. Subsequently, the antibodies were resuspended in sterile deionized
water at a concentration of 20 fold excess to the biotin concentration. Biotin and antibodies were
combined and incubated on ice for two hours. Once the incubation period ended, 2kD molecular
weight cut off dialysis cassettes (Slide-A-Lyzer, Thermo Scientific) was used to remove the
excess biotin from the reagents.
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2.4 BIOTINYLATING TYPE 5 HEXON PROTEIN
The Type 5 hexon proteins were biotinylated using the same method as the antibodies.
Because both are proteins, the same procedure applies. The concentration of antigen was 0.88
mg/ml. Thus, a 20-fold excess results in the addition of 20 mg/ml of the biotin reagent to the
solution as well. The antigens were resuspended in sterile deionized water with a concentration
of 20 fold excess to the biotin concentration. Type 5 hexon protein and biotin were combined
and incubated on ice for two hours, Once the incubation period ended, 2kD molecular weight cut
off dialysis cassettes (Slide-A-Lyzer, Thermo Scientific) was used to remove the excess biotin
from the reagents.
2.5 ATTACHING BIOTINYLATED ANTIBODIES TO PREPARED MICROSPHERES
Freshly biotinylated SP1 and Type 5 antibodies were incubated with the washed
streptavidin-coated microspheres at room temperature in the biohood for 30 minutes. Same
concentrations of both antibodies were added to the sample to allow for even dispersion on the
surface of the microspheres. The solution was mixed gently throughout the incubation period to
allow for a uniform bonding between the microspheres and the antibodies. Once the incubation
period was over, the antibody-covered microspheres were washed ten times in sterile deionized
water to remove any unbound biotinylated antibodies from the solution. The concentration of the
microspheres with bound antibodies was done using slow speed centrifugation. The antibodycoated beads were resuspended in 0.1M PBS at a pH of 7.4 to optimal storage concentration (0.5
mg-ml). The antibody-covered microspheres were stored at -20˚C in an Eppendorf tube. This
process was repeated to achieve the attachment of biotinylated Type 5 hexon proteins to
microspheres. This process can be visualized in figure 6.
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Figure 6: Illustration of the process of attaching biotinylated antibodies to microspheres from
Bangs Laboratories. The illustrated oligonucleotide represents the antibody or antigen used in
this procedure.

2.6 LABELLING SV40
The aliquot of SV40 that was used for this step was thawed at 4˚C for 12 hours before
using. A tenfold excess of antibody-covered microspheres was added to the virus. The virus and
the microspheres were incubated at 24˚C for 30 minutes under gentle agitation to allow the
VP1antibodies to bind to the attachment sites of the viral particles. Once the microspheres were
bound to the viral particles, the solution was filtered using a 0.2µm surfactant-free cellulose
acetate syringe filter (Fisher Scientific, 42213-CA). The microsphere complexes were eluted
from the filter using sterile deionized water. The unbound microspheres are slightly smaller than
the pore diameter of the filter, allowing for the sample to be mostly free of unbound
microspheres.
2.7 FORMATION OF MICROSPHERE COMPLEXES
Sterile deionized water was run through the photoacoustic glow cytometry system to
demonstrate the control background detection signal. 0.1 ml of sample containing only untagged
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SV40 was run through the system. No detections were observed for unbound SV40 showing the
absence of photo absorbers on its surface producing no photoacoustic response at 2mJ energy.
The purified sample of MC1’s was diluted to a total volume of 250µl and tittered through the
photoacoustic flow cytometry system. No microsphere complexes were detected by the system.
Next, the second layer of microspheres was bound to the microsphere complexes. Microspheres
covered in native Adenovirus Type 5 hexon protein were titrated in the sample of MC1’s and the
solution was incubated at room temperature for 30 minutes. The mixture was gently mixed
during the incubation period to allow for uniform attachment of the anti-adenovirus-antibodycovered microspheres over the surface of the MC1’s. The unbound microspheres were removed
from the sample again using a 0.2µm surfactant-free cellulose acetate syringe filter (Fisher
Scientific, 42213-CA). The newly formed second microsphere complexes were eluted from the
filter using sterile deionized water. This step yields a solution containing the double-layered
microsphere complexes MC2. The aliquot containing the newly formed MC2’s is tittered
through the photoacoustic flow cytometry system. The second microsphere complexes yield a
significant number of detections leading to the conclusion that covering single viral particles
with tagged microspheres allows for the detection of viral analytes in solution using PAFC.
CHAPTER 3: RESULTS

3.1 NEGATIVE CONTROLS
Deionized ultrapure water was run through the photoacoustic flow cytometry system to
assess the background noise level. Next, a sample containing solely viral particles was tittered
through the system. The solution of viral particles was tittered to a concentration of about 4000
virions per ml. Thus the expected number of detections is about 1000 virions per test. No
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detections were observed for virions alone or deionized ultrapure water, demonstrating their lack
of photo absorbing ability resulting in no production of a photoacoustic response using 2mJ
energy. CV-1 cells were also tittered through the system to make sure no remnant of the infected
cells could result in detections. CV-1 cells alone did not trigger a detection from the system.
Next, microspheres covered in SP1 and Type 5 antibodies were ran through the system. These
were still too small to reach the detection threshold of the system and get detected. SV40 and the
second layer of microspheres covered in Type 5 hexon proteins were combined in solution and
tittered through the system. No detection resulted from mixing the two incompatible analytes.
When the first microsphere complexes were analyzed in the system, one single detection was
observed in two of the three rounds of experiments. Table 2 illustrates the results obtained from
the negative control experiments.

Analyte
Detections Run 1 Detections Run 2 Detections Run 3
Ultrapure Water
0
0
0
SV40
0
0
0
VP1 Antibody + Type 5 Antibody Microspheres
0
0
0
Type 5 hexon protein Microspheres
0
0
0
CV-1 Cells
0
0
0
MC1
0
2
0
SV40 + Type 5 hexon protein Microspheres
0
0
0

Table 2: Negative controls showing that no analyte contained in the microsphere complexes
contain photo absorbing matter.
3.2 POSITIVE CONTROLS
As a test of positive controls, we first tested 1µm polystyrene black microspheres. We
added 4000 microspheres per milliliter. Each test was 250ul averaging 1000 microspheres per
test. We obtained constant detections demonstrating that our system is working properly and
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detects 1um microspheres. Next, unmodified 0.19um black microspheres were titrated in. No
detections were obtained until microspheres reached a 1x10^8 microspheres/ml concentration.
Table 3 illustrates the results obtained from the positive control experiments. As an additional
control, VP1 antibody tethered microspheres and Type 5 antibody tethered microspheres were
combined leading to the hypothesis that this would result in unrestricted binding causing all the
microspheres to form a large mass. The binding of these microspheres was visually observed
and caused a clog in the PAFC system and had to be mechanically resolved.

Concentration (Microspheres/ml) 0.19µm Microspheres 1µm Microspheres
1x10^5
0
513
1x10^6
0
962
1x10^7
0
>990
1x10^8
4
>990
1x10^9
2
>990
1x10^10
752
>990
Table 3: Positive controls showing that 0.19µm microspheres cannot absorb laser light until
present in a concentration of 108 microspheres/ml. 1µm microspheres absorb laser light much
better and can be detected starting from a 105 microspheres/ml concentration.
3.3 EXPERIMENTAL DATA
The experimental data is represented as ratios of analytes combined. The relative number
of viral particles is always 1 because we want to show that a single viral particle can be detected
by adding an appropriate number of microspheres. The data obtained from the ratio experiments
are shown in table 4. The assumption that six binding sites exist on the surface of each viral
particle justify the relative number of 6 antibody-covered microspheres added to the sample. By
saturating the surface of the viral particles with microspheres, we are assured that they will be
covered by the second layer of microspheres in the next step. Keeping a relatively low number of
antibody-covered microspheres also gives us insurance that the antigen-covered microspheres
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will bind to the complexes until saturation. The excess of antigen-bound microspheres will
remain free-floating in the sample and can be discarded. The data obtained from adding a ratio of
1000 Type 5 antigen microspheres is only slightly higher than the data obtained from adding a
ratio of 100 Type 5 antigen microspheres. Because the difference remains below one order of
magnitude, it is not justified to add ten times more Type 5 microspheres to the solution. The
same results are to be expected and less resources are needed. Table 5 illustrates the summarized
data leading to the conclusion that single viral particles can be detected by the PAFC system
using appropriately tagged microspheres.

Ratio (SV40: VP1/Type 5
Microspheres: Type 5 antigen Detections Run 1 Detections Run 2 Detections Run 3
Microspheres)
1:1:1
0
0
0
1:6:1
0
0
0
1:6:100
587
565
489
1:6:1000
603
611
599
Table 4: Experimental data showing that ratios of SV40 to VP1 antibody Microspheres to Type 5
hexon protein microspheres. Increasing the amount of Type 5 hexon protein microspheres does
not alter the outcome much because the surface area of the first microsphere.

Analyte
SV40 alone
MC1
MC2 (1:6:100)

Detections Run 1
0
1
587

Detections Run 2
0
1
565

Detections Run 3
0
0
489

Table 5: Summary of the experimental data. The number of detections obtained from the second
Microsphere Complexes is two orders of magnitude higher than that of the first Microsphere
Complexes.
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CHAPTER 4: DISCUSSION
This study demonstrates the ability of PAFC to be used for single viral particle detection
in vitro. Additionally, the method created uses a double layer of microspheres which represents
an advancement in specificity. This method complements the current demonstrated abilities of
the PAFC system and could be patented in the future.
No difference was observed between background noises observed from ultrapure water
and the viral sample. The data shows that 1µm black microspheres yield detections starting at
much lower concentrations than 0.19µm black microspheres. 0.19µm black microspheres do not
yield detections unless they are present in very high concentration in the sample. At 1x1010
microspheres/ml, we did obtain a significant detection level. Therefore, the presence of 19µm
black microspheres in solution does not alter the data because they are only detected by the
PAFC system when highly concentrated. Furthermore, we filtered out the unbound microspheres
before eluting the microsphere complexes and processing them. It is unlikely that enough
unbound microspheres are found in the sample that we obtain a false positive detection. The
experimental data shows a clear correlation between the formation of MC2’s and detections of
particles. After adding the first layer of microspheres on the viral particles and forming MC1’s,
no detections were obtained. Also, adding the second layer of microspheres in a ratio of 1:6:1
also does not yield detections. After adding Type 5 antigen-bound microspheres in a ratio of
1:6:100, we get a significant number of detections from the PAFC system. The pressure wave
resulting from the thermoelastic reaction within MC2’s in a ratio of 1:6:100 is greater than the
detection threshold of the transducer. The data shows that adding Type 5 antigen-tittered
microspheres to the sample in a ratio of 1:6:1000 does not result in a drastic change of the
number of detections obtained. Thus, is it not justified to add Type 5 antigen-bound
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microspheres to the sample in a ratio superior to 1:6:100. Table 5 aids the visualization of the
results obtained from the three main steps of this study. Viral particles alone do not contain
photo-absorbing matter and therefore cannot be detected by the PAFC system. As for the MC1’s,
we obtained one detection per run of 250µl sample. These complexes were made by adding a
concentration of 40 000 microspheres/ml to a 4000 viral particles/ml sample (1:10 viral particles
to microspheres ratio). Therefore, if MC1’s could be detectable by the PAFC system, we would
expect to see close to 1000 detections for the 250µl sample. However, we only obtained one
detection twice over three runs. Free-floating unbound MC1’s thus do not alter the MC2
detection data. The single detections can be attributed to undesired analytes present in the sample
or static charge build up caused by the polystyrene beads [18]. This is an area that can be
improved in the future to avoid false positive detections. The MC2’s detection data shows that
the noise resulting from the thermoelastic reaction within them can be detected by the PAFC
system. The initial number of viral particles added to the sample was about 1000 virions/test.
Due to the size of the added antibody-coated microspheres, it is possible that not all virions
became coated with microspheres, eliminating some viral particles from the sample. The
numbers of detections of MC2’s for each run is still more than half the initial number of viral
particles present in the sample. Also, it is two orders of magnitude higher than that of the viral
particles alone or MC1’s. Thus, we can affirm that the formation of a second microsphere
complex resulting in layers of PAFC detectable microspheres results in the detection of single
particle detection in sample. With this method of viral particle detection, the signal to noise ratio
used to detect melanoma and bacterial cells can be maintained to detected viral particles,
regardless of the size difference between the different analytes. This is an advantage, because if
allows the system to become more versatile and increase its application range without wasting
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time on energy-adjusting steps. The Photoacoustics procedure therefore remains the same and
any trained individual can analyze a viral particle sample with the method. Another advantage of
this method of viral detection is the time required to do the assay. A sample is prepared and
ready to be processed within an hour. This is a big change from the other viral assay techniques
currently used which are either not quantitative or require multiple days to yield results.

4.1 FUTURE DIRECTIONS
In the future, a way of increasing accuracy when using microsphere complexes with the
PAFC system to detect viral particles is through signal detection threshold modulation. Finding
the lower and higher bound of signal detection threshold for each complex will lead to the
formation of a detection ladder. The most significant detection threshold will be the average
threshold for the MC2’s. Any signal above the higher bound can be discarded and categorized as
an undesired analyte. Another way to better this system is if the laser energy is adjusted to
maximize the level at which the microsphere complexes are detected. Some complexes with a
lesser density or size might require a smaller amount of energy to get optimally detected. Some
experimenting will be helpful to determine the optimal nominal diameter of the microsphere for
different size ranges of viral particles. Additionally, the color of the chosen microspheres for
each layer can be chosen to be different in order to make the detection of a specific layer
possible. Specific wavelengths have a specific absorption spectrum. For this reason, pairing the
microsphere color to the laser wavelength brings an additional level of specificity to the method.
This addition could decrease the time needed for various types of particle detection. The
difficulty linked to the combination of two antibody-antigen pairs when constituting MC2 is that
the second pair needs to correspond to a virus that is not of interest. This is a necessary
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component of the assembly of the microsphere complex to avoid free-floating microspheres that
have attached to viral particles but that are not part of a microsphere complex. Consequently, an
“antibody cocktail” could be engineered to yield the most time-efficient detection of the analytes.
Statistical analysis would need to be performed and take into consideration multiple families of
viruses to yield the best combination needed to optimize targeted viral detection. Moreover, this
technique could be used to detect multiple analytes in a same sample. By using different colored
microspheres and being able to change the laser wavelength, one sample containing multiple
targeted particles can be analyzed in a fraction of the time needed to analyze multiple samples.
4.2 CONCLUSION
Timely and accurate detection of viral contaminates is important to control known or
unknown viral outbreaks. RT PCR has been the gold standard for viral particle identification
because of its ability to qualitatively identify the infectious particle. However, this method takes
at least 8 hours to carry on and is not quantitative. There exists a need for more rapid viral
diagnostics systems that can identify and quantify the contaminants to aid medical professional
administer the most relevant care to patients. The photoacoustic flow system paired with tagged
microspheres has the ability to not only qualitatively discriminate the viral particle in question,
but also to give a quantitative assay of the number of virions in a sample. This simple yet
innovative method of viral particle detection can also be expanded upon through signal detection
threshold modulation or by using microspheres with different absorbance spectra. This method
can be used in the future and refined to contribute to the timely need for relevant contributions
against viral outbreaks.
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